Building on the framework and success of the IVIg Rheumatology Program, the Neuromuscular Program was developed in 2012. The structure for the Neuromuscular Program was developed in consultation with a Provincial Neurology Taskforce. The program consists of guidance to support Transfusion Medicine screening of approved indications as well as centralized screening of possibly indicated, now referred to as conditionally approved, conditions after a short IVIg trial to determine effectiveness. With the expansion of the IVIg Neurology program to include Central Nervous System (CNS) conditions, the Neuromuscular Program was rebranded as the Neurology Program, where Neuromuscular conditions are now referred to as Peripheral Nervous System (PNS) conditions.
|
Peripheral Nervous System Clinical Resources for IVIG |
Dated |
| Jan 2017 | |
| Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) | |
|
Chronic Inflammatory Demyelinating Polyneuropathy Diagnostic and Treatment Algorithm |
Jan 2017 |
|
Reference for Chronic Inflammatory Demyelinating Polyneuropathy |
Jan 2017 |
| Guillain-Barré Syndrome (GBS) | |
| Jan 2017 | |
| Jan 2017 | |
| Jan 2017 | |
| Myasthenia Gravis (MG) | |
| Jan 2017 | |
| Jan 2017 | |
| Multifocal Motor Neuropathy (MMN) | |
|
Multifocal Motor Neuropathy Diagnostic and Treatment Algorithm |
Jan 2017 |
| Jan 2017 | |
Video: BC Neuromuscular IVIG Task Force: Review of Objectives and Process
To view the video, your computer must be compatible with Mediasite.
